Abstract:Long circulation, cell internalization, endosomal escape and small interfering RNA (siRNA) release to the cytoplasm are the prerequisite considerations for siRNA delivery vectors. Herein, a kind of sheddable nanoparticles (NPs) with micelle architecture for siRNA delivery were fabricated by using an intracellular-activated polycation-detachable copolymer (PECssD), which was prepared by introducing highly reducing environment-responsive disulfide linkages between PEGylated polycaprolactone (PCL) and the grafted polycation, poly(2-dimethylaminoethyl methacrylate) (PDMAEMA). The architecture of PECssD self-assembled NPs includes a biodegradable hydrophobic PCL core, a PEG shield and a detachable comb-like polycation surface. The stable nanosized complexes of PECssD NPs with siRNA, termed PECssD/siRNA micelleplexes, were formed, which could prolong circulation, improve accumulation and retention in tumor tissue, and be favorable for internalization. In particular, the cleavage of the disulfide linkages in the intracellular microenvironment and the subsequent dissociation of the PDMAEMA/siRNA polyplexes from the PEGylated PCL cores of PECssD/siRNA micelleplexes were also confirmed, which facilitated the endosomal escape and the efficient release of siRNA. As a result, the distribution of siRNA in cytoplasm was enhanced and subsequently promoted the efficiency of siRNA in gene silencing. Furthermore, systemic administration of the NPs carrying siPlk1 (polo-like kinase 1 specific siRNA) induced a tumor-suppressing effect in the HeLa-Luc xenograft murine model. Therefore, the devised strategy of the polycation-detachable copolymer PECssD NPs could address the requirements of the multistep systemic delivery process of siRNA. The hydrophobic core of the PECssD/siRNA micelleplexes is expected to entrap antitumor drugs or other therapeutic agents for combined therapies.

Antibody h-R3-dendrimer mediated siRNA has excellent endosomal escape and tumor targeted delivery ability, and represents efficient siPLK1 silencing and inhibition of cell proliferation, migration and invasion.

Redox-Responsive and Electrically Neutral PLGA Nanoparticles for Sirna Delivery in Human Cervical Carcinoma Cells

Enhanced Transfection Efficiency And Targeted Delivery Of Self-Assembling H-R3-Dendriplexes In Egfr-Overexpressing Tumor Cells

Efficient siRNA Delivery Using a Polyamidoamine Dendrimer with a Modified Pentaerythritol Core

Reversal of Multidrug Resistance in Breast Cancer MCF-7/ADR Cells by H-R3-simdr1-pamam Complexes

Non-Cationic RGD-Containing Protein Nanocarrier for Tumor-Targeted siRNA Delivery

Self-assembly Nanomicelles Based on Cationic Mpeg-Pla-b-polyarginine(r15) Triblock Copolymer for Sirna Delivery.

Polycation-detachable Nanoparticles Self-Assembled from Mpeg-Pcl-g-ss-pdmaema for in Vitro and in Vivo Sirna Delivery.

Integration of Polylactide into Polyethylenimine Facilitates the Safe and Effective Intracellular siRNA Delivery

EGF receptor targeted lipo-oligocation polyplexes for antitumoral siRNA and miRNA delivery

Transfection of 3′,3′′-Bis-peptide-sirna Conjugate by Cationic Lipoplexes Mixed with a Neutral Cytosin-1-yl-lipid

Lyophilized HER2-specific PEGylated immunoliposomes for active siRNA gene silencing.

Electrostatic Attractive Self‐Delivery of siRNA and Light‐Induced Self‐Escape for Synergistic Gene Therapy

In Vitro Studies of Phospholipid-Modified PAMAM-siMDR1 Complexes for the Reversal of Multidrug Resistance in Human Breast Cancer Cells.

Smart Nanoparticles Assembled by Endogenous Molecules for Sirna Delivery and Cancer Therapy Via CD44 and EGFR Dual-Targeting

Antibody-siRNA conjugates (ARCs) using multifunctional peptide as a tumor enzyme cleavable linker mediated effective intracellular delivery of siRNA

Novel Fluorinated Spermine and Small Molecule PEI to Deliver Anti-PD-L1 and Anti-VEGF siRNA for Highly Efficient Tumor Therapy

Construction of a Targeting Nanoparticle of 3′,3″-Bis-peptide-sirna Conjugate/Mixed Lipid with Postinserted DSPE-PEG2000-cRGD

Multifunctional triblock co-polymer mP3/4HB-b-PEG-b-lPEI for efficient intracellular siRNA delivery and gene silencing.

Rod-shaped polypeptide nanoparticles for siRNA delivery

The promotion of siRNA delivery to breast cancer overexpressing epidermal growth factor receptor through anti-EGFR antibody conjugation by immunoliposomes.